Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Malignant Melanoma

  Free Subscription

Articles published in Ophthalmology

Retrieve available abstracts of 46 articles:
HTML format

Single Articles

    June 2021
  1. BAKHOUM MF, Knight DK, Goldbaum MH
    Defining Extent of Diffuse Choroidal Melanoma with Indocyanine Green Angiography.
    Ophthalmology. 2021;128:834.

    November 2020
  2. FILI M, Seregard S, Stalhammar G
    Presenting symptoms are associated with uveal melanoma-related death.
    Ophthalmology. 2020 Nov 27. pii: S0161-6420(20)31118.

    July 2020
  3. JOUHI S, Heikkonen J, Reijonen V, Raivio V, et al
    Ophthalmology. 2020 Jul 7. pii: S0161-6420(20)30628.
    PubMed     Abstract available

    June 2020
  4. ESPENSEN CA, Kiilgaard JF, Appelt AL, Fog LS, et al
    Dose-response and normal tissue complication probabilities after proton therapy for choroidal melanomas.
    Ophthalmology. 2020 Jun 20. pii: S0161-6420(20)30572.
    PubMed     Abstract available

    May 2020
  5. BOGAARD J, Czaja R, Wirostko WJ
    Metastatic Choroidal Melanoma Treated with Ipilimimab.
    Ophthalmology. 2020;127:600.

    April 2020
  6. CHUANG K, Vortmeyer A, Liu S
    Conjunctival Fungal Ball Mimicking Melanoma.
    Ophthalmology. 2020;127:534.

  7. JAMPOL LM, Moy CS, Murray TG, Reynolds SM, et al
    The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma: IV. Local Treatment Failure and Enucleation in the First 5 Years after Brachytherapy. COMS Report No. 19.
    Ophthalmology. 2020;127.
    PubMed     Abstract available

  8. SALOWE R, O'Brien JM
    The Collaborative Ocular Melanoma Study Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma.
    Ophthalmology. 2020;127.

    January 2020
  9. MANTA A, Goldberg RA
    Pembrolizumab-Related Enophthalmos.
    Ophthalmology. 2020;127:121.

    November 2019
  10. ABDEL-RAHMAN MH, Sample KM, Pilarski R, Walsh T, et al
    Whole Exome Sequencing Identifies Candidate Genes Associated with Hereditary Predisposition to Uveal Melanoma.
    Ophthalmology. 2019 Nov 18. pii: S0161-6420(19)32274.
    PubMed     Abstract available

  11. LI J, Seider MI
    Pseudomelanoma: Spontaneous Myopic Choroidal Hemorrhage.
    Ophthalmology. 2019;126:1491.

    October 2019
  12. VAN IPENBURG JA, Gillis Ing AJM, Dorssers LCJ, van den Bosch QCC, et al
    MicroRNA Profiling in Benign and Malignant Conjunctival Melanocytic Lesions.
    Ophthalmology. 2019 Oct 12. pii: S0161-6420(19)32142.

    September 2019
  13. FRANCIS JH, Berry D, Abramson DH, Barker CA, et al
    Intravitreous Cutaneous Metastatic Melanoma in the Era of Checkpoint Inhibition: Unmasking and Masquerading.
    Ophthalmology. 2019 Sep 24. pii: S0161-6420(19)32085.
    PubMed     Abstract available

    April 2019
  14. VICHITVEJPAISAL P, Dalvin LA, Mazloumi M, Ewens KG, et al
    Genetic Analysis of Uveal Melanoma in 658 Patients using The Cancer Genome Atlas (TCGA) Classification of Uveal Melanoma as A, B, C & D.
    Ophthalmology. 2019 Apr 23. pii: S0161-6420(19)30611.
    PubMed     Abstract available

    Understanding Uveal Melanoma Metastasis to the Liver: The Zimmerman Effect and the Zimmerman Hypothesis.
    Ophthalmology. 2019;126:483-487.

  16. ABRAMSON DH, Francis JH
    Pseudomelanoma (with Cataract) in a Child Caused by Amniocentesis.
    Ophthalmology. 2019;126:590.

    December 2018
  17. MUDHAR HS, Doherty RE, Salvi SM, Currie ZI, et al
    Genetic Profiling of Primary Orbital Melanoma-An Analysis of 6 Cases with Clinico-Pathological Correlation.
    Ophthalmology. 2018 Dec 31. pii: S0161-6420(18)32892.

  18. PAPUDESU C, Reddy SG, Potter HD
    Ocular Metastasis of Cutaneous BRAF Wild-Type Melanoma.
    Ophthalmology. 2018;125:1966.

    November 2018
  19. SCHOLZ SL, Murali R, Westekemper H, Schadendorf D, et al
    Re: van Poppelen et al.: Genetic background of iris melanomas and iris melanocytic tumors of uncertain malignant potential (Ophthalmology. 2018;125:904-912).
    Ophthalmology. 2018;125:e78-e79.

  20. BEVER GJ, Seider MI
    Two-Toned Lipofuscin in the Same Choroidal Melanoma: Orange versus Gray.
    Ophthalmology. 2018;125:1792.

    August 2018
  21. JAGER MJ, Brouwer NJ, Esmaeli B
    The Cancer Genome Atlas Project: An Integrated Molecular View of Uveal Melanoma.
    Ophthalmology. 2018;125:1139-1142.

    July 2018
  22. ROELOFS K, Puttagunta L, Weis E
    Choroidal Melanoma with Overlying Lipofuscin Sediment.
    Ophthalmology. 2018;125:1053.

    May 2018
  23. DAMATO B
    Predicting Choroidal Melanoma Regression after Brachytherapy.
    Ophthalmology. 2018;125:755-756.

  24. MICIELI JA, Newman NJ, Biousse V
    Retinal Imaging of an Optic Tract Lesion: OCT Angiography of Structural and Functional Defects.
    Ophthalmology. 2018;125:756.

    April 2018
  25. BAGGER M, Smidt-Nielsen I, Andersen MK, Jensen PK, et al
    Long-Term Metastatic Risk after Biopsy of Posterior Uveal Melanoma.
    Ophthalmology. 2018 Apr 25. pii: S0161-6420(17)33868.
    PubMed     Abstract available

  26. AFSHAR AR, Damato BE, Stewart JM, Heimann H, et al
    Re: Reddy et al.: Vitrectomy and vitrector port needle biopsy of choroidal melanoma for gene expression profile testing immediately before brachytherapy. (Ophthalmology. 2017;124:1377-1382).
    Ophthalmology. 2018;125:e28-e29.

  27. RAMAKRISHNAN M, Vora R, Seider MI
    Oculodermal Melanocytosis, Darker Complexion, Choroidal Melanoma: A Missed Clue.
    Ophthalmology. 2018;125:494.

    February 2018
  28. RASHID M, Heikkonen J, Singh AD, Kivela TT, et al
    Clinical Predictors of Regression of Choroidal Melanomas after Brachytherapy: A Growth Curve Model.
    Ophthalmology. 2018 Feb 27. pii: S0161-6420(17)33252.
    PubMed     Abstract available

    January 2018
  29. VAN POPPELEN NM, Vaarwater J, Mudhar HS, Sisley K, et al
    Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential.
    Ophthalmology. 2018 Jan 19. pii: S0161-6420(17)32844.
    PubMed     Abstract available

  30. SHIELDS CL, Di Nicola M, Bekerman VP, Kaliki S, et al
    Iris Melanoma Outcomes Based on the American Joint Committee on Cancer Classification (Eighth Edition) in 432 Patients.
    Ophthalmology. 2018 Jan 13. pii: S0161-6420(17)32069.
    PubMed     Abstract available

    November 2017
  31. THARIAT J, Rahmi A, Salleron J, Mosci C, et al
    Proton Beam Therapy for Iris Melanomas in 107 Patients.
    Ophthalmology. 2017 Nov 8. pii: S0161-6420(17)32582.
    PubMed     Abstract available

  32. LIAO A, Mittal P, Lawson DH, Yang JJ, et al
    Radiologic and Histopathologic Correlation of Different Growth Patterns of Metastatic Uveal Melanoma to the Liver.
    Ophthalmology. 2017 Nov 6. pii: S0161-6420(17)32368.
    PubMed     Abstract available

    October 2017
  33. AYRES B, Elner V, Demirci H
    Massive Extraocular Extension of Choroidal Melanoma after Brachytherapy.
    Ophthalmology. 2017;124:1503.

    September 2017
  34. VALSECCHI ME, Orloff M, Sato R, Chervoneva I, et al
    Adjuvant Sunitinib in High-Risk Patients with Uveal Melanoma: Comparison with Institutional Controls.
    Ophthalmology. 2017 Sep 18. pii: S0161-6420(17)30329.
    PubMed     Abstract available

    August 2017
  35. SZALAI E, Wells JR, Ward L, Grossniklaus HE, et al
    Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis.
    Ophthalmology. 2017 Aug 17. pii: S0161-6420(17)31332.
    PubMed     Abstract available

    June 2017
  36. WALTER SD, Cummings TJ, Mruthyunjaya P
    Anterior Chamber Angle Invasion of Iridociliary Melanoma.
    Ophthalmology. 2017;124:842.

    May 2017
  37. MRUTHYUNJAYA P, Seider MI, Stinnett S, Schefler A, et al
    Association between Tumor Regression Rate and Gene Expression Profile after Iodine 125 Plaque Radiotherapy for Uveal Melanoma.
    Ophthalmology. 2017 May 23. pii: S0161-6420(16)31873.
    PubMed     Abstract available

  38. SHIELDS CL, Say EAT, Hasanreisoglu M, Saktanasate J, et al
    Personalized Prognosis of Uveal Melanoma Based on Cytogenetic Profile in 1059 Patients over an 8-Year Period: The 2017 Harry S. Gradle Lecture.
    Ophthalmology. 2017 May 7. pii: S0161-6420(17)30398.
    PubMed     Abstract available

  39. PELLEGRINI M, Staurenghi G
    Swept-source Optical Coherence Tomography Angiography Imaging in a Case of Uveal Melanoma.
    Ophthalmology. 2017;124:729.

    April 2017
  40. REDDY DM, Mason LB, Mason JO 3rd, Crosson JN, et al
    Vitrectomy and Vitrector Port Needle Biopsy of Choroidal Melanoma for Gene Expression Profile Testing Immediately before Brachytherapy.
    Ophthalmology. 2017 Apr 28. pii: S0161-6420(16)32000.
    PubMed     Abstract available

  41. MOKHTARZADEH A, Harrison AR, Maltry AC
    Malignant Orbital Melanoma Associated with Oculodermal Melanocytosis.
    Ophthalmology. 2017;124:561.

  42. CHAUGULE SS, Finger PT
    Regression Patterns of Iris Melanoma after Palladium-103 (103Pd) Plaque Brachytherapy.
    Ophthalmology. 2017 Apr 1. pii: S0161-6420(17)30011.
    PubMed     Abstract available

    January 2017
  43. SHIELDS CL, Say EA, Hasanreisoglu M, Saktanasate J, et al
    Cytogenetic Abnormalities in Uveal Melanoma Based on Tumor Features and Size in 1059 Patients: The 2016 W. Richard Green Lecture.
    Ophthalmology. 2017 Jan 31. pii: S0161-6420(16)31846.
    PubMed     Abstract available

    December 2016
  44. JACINTO FA, Margo CE
    Neglected Choroidal Melanoma Tracking Along Optic Nerve to Brain.
    Ophthalmology. 2016;123:2488.

  45. YAVUZYIGITOGLU S, Drabarek W, Smit KN, van Poppelen N, et al
    Correlation of Gene Mutation Status with Copy Number Profile in Uveal Melanoma.
    Ophthalmology. 2016 Dec 1. pii: S0161-6420(16)31717.

    November 2016
  46. SKALET AH, Li Y, Lu CD, Jia Y, et al
    Optical Coherence Tomography Angiography Characteristics of Iris Melanocytic Tumors.
    Ophthalmology. 2016 Nov 14. pii: S0161-6420(16)31328.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.